CORE
🇺🇦
make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
A dose escalating study of cabazitaxel (XRP6258) in combination with capecitabine, in patients (pts) with metastatic breast cancer (MBC) progressing after anthracycline and taxane therapy
Authors
15th Congress of the European-Cancer-Organization/34th Multidisciplinary Congress of the European-Society-for-Medical-Oncology
A. Awada
+8 more
T. Besse
M. Campone
F. Dubin
Jean-Pascal Machiels
E. Magherini
X. Pivot
D. Semiond
C. Villanueva
Publication date
1 January 2009
Publisher
Pergamon
Abstract
Abstract is not available.
Similar works
Full text
Available Versions
DIAL UCLouvain
See this paper in CORE
Go to the repository landing page
Download from data provider
oai:dial.uclouvain.be:boreal:5...
Last time updated on 14/05/2016
